Document is current
Any future updates will be listed below
-
Authors
Qu, Mingli
Wang, Qun
Bai, Xiaofei
Feng, Jing https://orcid.org/0000-0003-3719-9319
Zhang, Sai
Zhang, Yangyang
Chen, Qing
Zhu, Hai
Zhang, Hengrui
Guo, Qunqin
Zhang, Bin
Dou, Shengqian
Qiao, Yujie
Wang, Hongwei
Cao, Yihai https://orcid.org/0000-0003-1308-0065
Xie, Lixin
Zhou, Qingjun https://orcid.org/0000-0002-7770-9275
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 27 May 2025
First Online: 5 June 2025
Competing interests
: A Chinese patent (ZL202210497086.8) has been granted to Eye Institute of Shandong First Medical University (Shandong Eye Institute, Qingdao Eye Hospital of Shandong First Medical University), with inventors Lixin Xie, Qingjun Zhou, Mingli Qu, and Sai Zhang. It covers the use of sympathetic activation inhibitors and/or α1-adrenergic receptor antagonists for treating dry eye. A related PCT application (PCT/CN2022/113244) is under examination. All other authors declare no competing interests.
